Placeholder

A Changing Market Environment Requires New PLM Strategies

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

In a market environment that is increasingly value-based, the industry must begin to review its product life-cycle management (PLM) strategy and prepare for more effective ways to cope with the evolving challenges when it comes to pipeline maintenance. For example, companies need to start implementing PLM earlier than ever before. Instead of approaching PLM as a solution to patent expiry, companies need to consider the complete life cycle, and view PLM as a way to best take advantage of all stages of the product.
Today, companies that don’t plan their life-cycle options early — starting at the end of Phase I/beginning of Phase II — will struggle. Our experts say starting earlier will prove to be an organizational challenge, and hence, a company’s culture will become equally important and require a new emphasis on leadership development that will create…

Sidebars:
PLM Adoption Factors
Three PLM Trends

Experts
Rob Bazemore
. President, Janssen Biotech Inc., a company that is focused on advancing the standard of care in ­immunology, oncology, urology, and nephrology, and one of the Janssen ­Pharmaceutical companies. For more ­information, visit janssenbiotech.com.
Chris Bogan. CEO, Best ­Practices LLC, a research, ­consulting, database, and ­publishing firm. For more ­information, visit best-in-class.com or email cbogan@best-in-class.com.
Ron Burns. CEO, ProtonMedia, which ­develops ProtoSphere, a virtual ­collaboration ­environment for ­high-performance workplaces and a virtual environment for collaborative PLM in life sciences. For more information, visit ­protonmedia.com.
Andrew Hunter. Senior Manager, Kalypso, a consulting firm that helps clients drive profitable, sustained ­results. For more information, visit ­kalypso.com.
Mike Rea. Principal, IDEA Pharma, which specializes in path-to-market strategy at Phase II, transforming the probability of commercial success for any molecule. For more information, visit ideapharma.com or email mike.rea@ideapharma.com.

FEEDBACK